Fig. 2

Identification of tumor antigens associated with the clinical outcome of LGG and GBM in TCGA cohort. A–D Kaplan–Meier curves showing OS of LGG and GBM patients stratified on the basis of A PTBP1, B SLC39A1, C MMP9, and D SLC16A3 expression levels